• About
  • Subscribe
  • Advertise
  • Contact
Wednesday, July 15, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home

RANZCO challenges evidence behind behavioural optometry

by Staff Writer
February 5, 2018
in Research
Reading Time: 4 mins read
A A
Share on FacebookShare on Twitter

The statent said there is no evidence behavioural optometry treatments help children with dyslexia and learning difficulties improve their reading, and that the college had an obligation to safeguard patients from treatments that lack clinical or scientific merit.{{quote-a:r-W:450-I:2-Q:“Reviews of the literature have consistently shown a lack of good evidence to support vision therapies, such as those offered by behavioural optometrists, for the treatment of learning disabilities such as dyslexia.”-WHO:James Elder, RANZCO}}“Ophthalmologists, like mainstream optometrists, are very passionate about saving sight and don’t like to see resources intended for health and wellbeing being misdirected. Reviews of the literature have consistently shown a lack of good evidence to support vision therapies, such as those offered by behavioural optometrists, for the treatment of learning disabilities such as dyslexia,” RANZCO’s Associate Professor James Elder said.“Using these expensive, ineffective and controversial treatments may delay a child from receiving the appropriate evidence-based educational redies. Evidence shows that the earlier the intervention with the appropriate redial programs, the more effective they are in improving reading outcomes.”Elder also explained that, “The use of ineffective interventions may also waste the limited financial resources of the family as well as giving th a false sense of security that the child’s reading difficulties are being addressed.”However, the Australasian College of Behavioural Optometrists (ACBO) responded by saying it was disappointed RANZCO had perpetuated what it said were mistaken and unjustified assertions related to behavioural optometrists treating dyslexia, and the validity of treatments such as vision therapy.“ACBO mbers do not treat dyslexia or other learning difficulties. ACBO policy explicitly states that optometrists treat learning-related vision probls that occur concurrently with probls like dyslexia and can have a significant effect on visual performance and learning. Ophthalmology research has shown that children with dyslexia have a significantly higher incidence of visual probls than their unaffected peers,” the statent read.“Clinical evidence for behavioural optometry and vision therapy is substantial and rigorous, and continues to expand with new generations of clinicians, acadics and researchers. Treatments such as vision therapy are also recommended and offered by ophthalmologists and orthoptists.”However, despite challenging RANZCO’s assessment of behavioural optometry therapies, ACBO said the college’s position had “largely agreed” with its own 2016 position statent regarding Irlen Syndrome and its related treatments.Irlen SyndromeFirst described in the early 1980s as a perceptual learning disorder, Irlen Syndrome suggests that the brain is unable to properly process visual information from the eyes because of sensitivity to certain wavelengths of light. Symptoms are said to include poor concentration; difficulties with reading, writing and comprehension; glare sensitivity; headaches and poor depth perception, however RANZCO has stated there is no evidence that the condition actually exists.{{quote-a:r-w:400-Q:“Clinical evidence for behavioural optometry and vision therapy is substantial and rigorous, and continues to expand with new generations of clinicians, acadics and researchers.”-WHO:ACBO statent.}}“The real concern with diagnoses of Irlen Syndrome is that it can distract from genuine diagnosis and treatment, such as a comprehensive evaluation by an educational psychologist followed by the appropriate redial educational input,” RANZCO spokesperson Professor Frank Martin said.“Any interventions that distract from and delay this evaluation could be detrimental to the effective treatment of any learning disabilities.”According to RANZCO, treatments associated with Irlen Syndrome, such as coloured lenses, have not proved to be any more effective in improving reading difficulties in children than in children assessed in a control group.While there is no documented evidence to say that Irlen lenses are harmful, the position statent went on to explain that their use could waste time and money, and substitute the use of evidence-based treatments.“Overwhelmingly the research shows no benefit from this treatment in children with reading difficulties, and vulnerable parents are being exploited and having their children subjected to unnecessary screening practices,” Martin said.More reading: RANZCO Position Statent.
ACBO Response.Image courtesy: Flickr | NicoleKlauss

Related Posts

UNSW has achieved a top ranking. Image: UNSW.

UNSW named No. 1 in world for optometry research excellence

by Staff Writer
July 9, 2026

The UNSW School of Optometry & Vision Science has been recognised as the world's leading optometry school for research excellence,...

If you are not enjoying what you are doing or not looking forward to heading into work, that is one sign of stress and anxiety, says
Dr Anne Malatt. Image: Andrii/stock.adobe.com.

Special Report: Seeing everyone but themselves – mental health and eye surgery

by Rob Mitchell
July 6, 2026

Stress, anxiety and burnout remain hidden challenges in ophthalmology. Two practitioners bring that out into the open and talk about...

Figure 1 shows population coverage, defined as the number of people served per full-time-equivalent optometrist. Image: Dr Matt Trinh.

Soapbox: Maldistribution not the biggest problem in optometry

by Dr Matt Trinh
July 1, 2026

Australia’s optometry workforce debate often defaults to maldistribution and the idea that we have enough optometrists but in the wrong...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Products
    • Ophthalmic Treatments
      • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited